Marshall Wace’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Marshall Wace’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,064	Closed	-$23.5K	–	2715
2024 Q2	$23.5K	Sell	14,064 -57,024	-80%	-$102K	﹤0.01%	2468
2024 Q1	$132K	Buy	+71,088	New	+$131K	﹤0.01%	2279
2022 Q3	–	Sell	-104,478	Closed	-$1.18M	–	3548
2022 Q2	$1.18M	Buy	+104,478	New	+$1.25M	﹤0.01%	2344
2022 Q1	–	Sell	-12,820	Closed	-$606K	–	3639
2021 Q4	$606K	Buy	+12,820	New	+$769K	﹤0.01%	2705
2021 Q2	–	Sell	-53,596	Closed	-$2.6M	–	2836
2021 Q1	$2.6M	Sell	53,596 -97,289	-64%	-$5.28M	0.01%	1182
2020 Q4	$7.11M	Buy	150,885 +76,288	+102%	+$3M	0.04%	450
2020 Q3	$3.51M	Buy	+74,597	New	+$2.46M	0.02%	635

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Marshall Wace's NBP Position: Q3 2024 in Review

Marshall Wace sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2024, closing a stake of 14,064 shares — an estimated $23.5K sold.

Marshall Wace first reported a position in NBP in Q3 2020 and held it in 7 quarters. The position peaked at $7.11M in Q4 2020. 28 funds tracked by Wall St. Rank hold NBP as of Q3 2024.

Marshall Wace reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Marshall Wace sold 14,064 NovaBridge Biosciences American Depositary Shares shares in Q3 2024, an estimated $23.5K.
Marshall Wace first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 7 quarters.
Marshall Wace's NovaBridge Biosciences American Depositary Shares position peaked at $7.11M in Q4 2020.
28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.